about
Development of Surface-Variable Polymeric Nanoparticles for Drug Delivery to Tumors.Intraperitoneal delivery of platinum with in-situ crosslinkable hyaluronic acid gel for local therapy of ovarian cancer.Drug delivery to macrophages: Challenges and opportunities.Particle engineering for intracellular delivery of vancomycin to methicillin-resistant Staphylococcus aureus (MRSA)-infected macrophages.Intraperitoneal chemotherapy of ovarian cancer by hydrogel depot of paclitaxel nanocrystals.Polymer-iron oxide composite nanoparticles for EPR-independent drug delivery.Programmed Cell Death Protein Ligand-1 Silencing with Polyethylenimine-Dermatan Sulfate Complex for Dual Inhibition of Melanoma Growth.Radiation-enhanced delivery of plasmid DNA to tumors utilizing a novel PEI polyplex.Small molecule delivery to solid tumors with chitosan-coated PLGA particles: A lesson learned from comparative imaging.Enhancing Docetaxel Delivery to Multidrug-Resistant Cancer Cells with Albumin-Coated Nanocrystals.Polyethylenimine-dermatan sulfate complex, a bioactive biomaterial with unique toxicity to CD146-positive cancer cells.Succinylated chitosan derivative has local protective effects on intestinal inflammation.Albumin-coated nanocrystals for carrier-free delivery of paclitaxel.A Comparative In Vivo Study of Albumin-Coated Paclitaxel Nanocrystals and Abraxane.Quantitative Assessment of Nanoparticle Biodistribution by Fluorescence Imaging, RevisitedQuinic Acid-Conjugated Nanoparticles Enhance Drug Delivery to Solid Tumors via Interactions with Endothelial SelectinsCamouflaging Nanoparticles for Ratiometric Delivery of Therapeutic CombinationsMagnetophoretic Delivery of a Tumor-Priming Agent for Chemotherapy of Metastatic Murine Breast Cancer.Sustained Delivery of Carfilzomib by Tannic Acid-Based Nanocapsules Helps Develop Antitumor ImmunitySurface Modification of Polymeric Nanoparticles with M2pep Peptide for Drug Delivery to Tumor-Associated MacrophagesDevelopment of Liposomal Gemcitabine with High Drug Loading Capacity
P50
Q33870874-71F2F4EA-2FDC-41FA-80DB-FE396802C686Q35032664-A552E1A1-2E68-48C8-AB44-93EC7579A152Q38674281-06EB039B-E9AB-4C3B-84BC-2D8E47810EB3Q40098168-37983E38-1B6D-44E7-B18F-FFA91346DB0DQ42321339-378BF9DD-8551-43BE-9A48-A0F413BB91C8Q42534599-EAB4691D-4286-4D44-B9EB-29681BF1746BQ46098250-CB849C3E-CBC3-4886-8636-1B669682DBE8Q47236738-DEBAE605-0E8C-49FC-99CF-92E7772CE1D8Q47374159-01E39D07-8203-410F-A580-CC1888980708Q47712879-94A132D6-0F62-4F68-9A03-C3D545B981D8Q49864679-41856CE8-CB27-40B5-8418-EAC5F6F90132Q49953574-78E2AD2F-F474-4FED-A8BD-984BB236083DQ51061843-609C010E-43F3-4DD6-8EBD-B4D693F67338Q53077565-53BC66B6-8DB1-4436-8943-62DF66F37D5AQ57174825-405FF083-4CF4-4E18-A7C7-302F04AF4642Q58571806-365C0A01-F74C-4185-829D-9318915887A0Q64264885-54B63A77-A7C8-40E5-B402-36275AFDE3FEQ64991479-A82A647B-3539-4D05-91B3-3A5E62822AEEQ90969260-A67AEF82-1CDE-43AA-8FDB-2850ED5A2D8BQ92288323-B9D9A70D-AF45-46BD-A7F1-25F0F8A22B8EQ92343750-98053E71-C57C-4588-8036-9C2EECA8BC17
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Yoon Yeo
@ast
Yoon Yeo
@en
Yoon Yeo
@es
Yoon Yeo
@nl
Yoon Yeo
@sl
type
label
Yoon Yeo
@ast
Yoon Yeo
@en
Yoon Yeo
@es
Yoon Yeo
@nl
Yoon Yeo
@sl
prefLabel
Yoon Yeo
@ast
Yoon Yeo
@en
Yoon Yeo
@es
Yoon Yeo
@nl
Yoon Yeo
@sl
P106
P31
P496
0000-0001-9505-7701